G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based Map

PLoS Medicine

Volumn 9, Issue 11, 2012, Pages

  Howes, Rosalind E ^a   Piel, Frédéric B ^a   Patil, Anand P ^a   Nyangiri, Oscar A ^b   Gething, Peter W ^a   Dewi, Mewahyu ^c   Hogg, Mariana M ^a   Battle, Katherine E ^a   Padilla, Carmencita D ^d,e   Baird, J Kevin ^c,f   Hay, Simon I ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^d UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRIMAQUINE;

ARTICLE; BAYES THEOREM; DISEASE SEVERITY; ENDEMIC DISEASE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GEOGRAPHIC DISTRIBUTION; GEOSTATISTICAL ANALYSIS; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH SURVEY; HEMOLYSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MALARIA; POPULATION DENSITY; PREVALENCE; RISK ASSESSMENT;

ANTIMALARIALS; BAYES THEOREM; FEMALE; GENE FREQUENCY; GEOGRAPHIC MAPPING; GEOGRAPHY, MEDICAL; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYSIS; HUMANS; MALARIA; MALE; MODELS, GENETIC; PREVALENCE; PRIMAQUINE; RISK ASSESSMENT; SEX DISTRIBUTION;

EID: 84870267029     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001339     Document Type: Article

References (81)

1. Feachem RG, Phillips AA, Hwang J, Cotter C, Wielgosz B, et al. (2010) Shrinking the malaria map: progress and prospects. Lancet 376: 1566-1578.
2. Das P, Horton R, (2010) Malaria elimination: worthy, challenging, and just possible. Lancet 376: 1515-1517.
3. The Global Health Group and the Malaria Atlas Project (2011) Atlas of malaria-eliminating countries. San Francisco: The Global Health Group, Global Health Sciences, University of California, San Francisco.
4. Moonen B, Cohen JM, Snow RW, Slutsker L, Drakeley C, et al. (2010) Operational strategies to achieve and maintain malaria elimination. Lancet 376: 1592-1603.
5. Carlton JM, Sina BJ, Adams JH, (2011) Why is Plasmodium vivax a neglected tropical disease? PLoS Negl Trop Dis 5: e1160 doi:10.1371/journal.pntd.0001160.
6. Gosling RD, Okell L, Mosha J, Chandramohan D, (2011) The role of antimalarial treatment in the elimination of malaria. Clin Microbiol Infect 17: 1617-1623.
7. Karl S, Gurarie D, Zimmerman PA, King CH, St Pierre TG, et al. (2011) A sub-microscopic gametocyte reservoir can sustain malaria transmission. PLoS One 6: e20805 doi:10.1371/journal.pone.0020805.
8. Wells TN, Burrows JN, Baird JK, (2010) Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. Trends Parasitol 26: 145-151.
9. White NJ, (2008) The role of anti-malarial drugs in eliminating malaria. Malar J 7 (Suppl 1):: S8.
10. Baird JK, Schwartz E, Hoffman SL, (2007) Prevention and treatment of vivax malaria. Curr Infect Dis Rep 9: 39-46.
11. Baird JK, (2010) Eliminating malaria- all of them. Lancet 376: 1883-1885.
12. Cappellini MD, Fiorelli G, (2008) Glucose-6-phosphate dehydrogenase deficiency. Lancet 371: 64-74.
13. Shanks GD, Kain KC, Keystone JS, (2001) Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future. Clin Infect Dis 33: 381-385.
14. WHO (2010) Guidelines for the treatment of malaria, second edition. Geneva: World Health Organization.
15. WHO (2010) World malaria report 2010. Geneva: World Health Organization.
16. WHO (2011) Global plan for artemisinin resistance containment (GPARC). Geneva: World Health Organization.
17. Song J, Socheat D, Tan B, Dara P, Deng C, et al. (2010) Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine. Malar J 9: 57.
18. Lawpoolsri S, Klein EY, Singhasivanon P, Yimsamran S, Thanyavanich N, et al. (2009) Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations. Malar J 8: 159.
19. Graves PM, Gelband H, Garner P, (2012) Primaquine for reducing Plasmodium falciparum transmission. Cochrane Database Syst Rev 9: CD008152.
20. Shekalaghe SA, Bousema JT, Kunei KK, Lushino P, Masokoto A, et al. (2007) Submicroscopic Plasmodium falciparum gametocyte carriage is common in an area of low and seasonal transmission in Tanzania. Trop Med Int Health 12: 547-553.
21. Global Malaria Programme (2007) Malaria elimination: A field manual for low and moderate endemic countries. Geneva: World Health Organization.
22. The malERA Consultative Group on Diagnoses Diagnostics (2011) A research agenda for malaria eradication: diagnoses and diagnostics. PLoS Med 8: e1000396 doi:10.1371/journal.pmed.1000396.
23. Douglas NM, Nosten F, Ashley EA, Phaiphun L, van Vugt M, et al. (2011) Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics. Clin Infect Dis 52: 612-620.
24. Baird JK, Surjadjaja C, (2011) Consideration of ethics in primaquine therapy against malaria transmission. Trends Parasitol 27: 11-16.
25. Brueckner RP, Ohrt C, Baird JK, Milhous WK (2001) 8-Aminoquinolines. Rosenthal PJ, editor. Antimalarial chemotherapy: mechanisms of action, resistance, and new directions in drug discovery. Totowa (New Jersey): Humana Press.
26. Beutler E, (1994) G6PD deficiency. Blood 84: 3613-3636.
27. Abeyaratne KP, Halpe NL, (1968) Sensitivity to primaquine in Ceylonese children due to deficiency of erythrocytic glucose-6-phosphate dehydrogenase. Ceylon Med J 13: 134-138.
28. Burgoine KL, Bancone G, Nosten F, (2010) The reality of using primaquine. Malar J 9: 376.
29. The malERA Consultative Group on Drugs (2011) A research agenda for malaria eradication: drugs. PLoS Med 8: e1000402 doi:10.1371/journal.pmed.1000402.
30. APMEN Vivax working group. Annual Business and Technical meeting; 2011; Kota Kinabalu, Malaysia. Available: http://apmen.org/storage/apmen-iii/Dr%20Ric%20Price.pdf. Accessed 8 February 2012.
31. WHO Working Group (1989) Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ 67: 601-611.
32. Luzzatto L, Notaro R, (2001) Malaria. Protecting against bad air. Science 293: 442-443.
33. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E, (2009) The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis 42: 267-278.
34. Cavalli-Sforza LL, Menozzi P, Piazza A (1994) The history and geography of human genes. Princeton (New Jersey): Princeton University Press. 1088 p.
35. Padilla CD, Therrell BL, (2007) Newborn screening in the Asia Pacific region. J Inherit Metab Dis 30: 490-506.
36. Singh S, (1973) Distribution of certain polymorphic traits in populations of the Indian peninsula and South Asia. Isr J Med Sci 9: 1225-1237.
37. Mourant AE, Kopec AC, Domaniewska-Sobczak K (1976) The distribution of the human blood groups and other polymorphisms. London: Oxford University Press.
38. Livingstone FB (1985) Frequencies of hemoglobin variants: thalassemia, the glucose-6-phosphate dehydrogenase deficiency, g6pd variants and ovalocytosis in human populations. New York: Oxford University Press.
39. Guerra CA, Hay SI, Lucioparedes LS, Gikandi PW, Tatem AJ, et al. (2007) Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project. Malar J 6: 17.
40. Howes RE, Patil AP, Piel FB, Nyangiri OA, Kabaria CW, et al. (2011) The global distribution of the Duffy blood group. Nat Commun 2: 266.
41. Hay SI, Guerra CA, Gething PW, Patil AP, Tatem AJ, et al. (2009) A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med 6: e1000048 doi:10.1371/journal.pmed.1000048.
42. Diggle PJ, Ribeiro PJ, Jr (2007) Model-based Geostatistics: Springer.
43. Diggle P, Moyeed R, Rowlingson B, Thomson M, (2002) Childhood malaria in the Gambia: a case-study in model-based geostatistics. J Roy Stat Soc C-App 51: 493-506.
44. Clements AC, Moyeed R, Brooker S, (2006) Bayesian geostatistical prediction of the intensity of infection with Schistosoma mansoni in East Africa. Parasitology 133: 711-719.
45. Magalhaes RJ, Clements AC, (2011) Mapping the risk of anaemia in preschool-age children: the contribution of malnutrition, malaria, and helminth infections in West Africa. PLoS Med 8: e1000438 doi:10.1371/journal.pmed.1000438.
46. Raso G, Matthys B, N'Goran EK, Tanner M, Vounatsou P, et al. (2005) Spatial risk prediction and mapping of Schistosoma mansoni infections among schoolchildren living in western Cote d'Ivoire. Parasitology 131: 97-108.
47. Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, et al. Global estimates of sickle haemoglobin in newborns. Lancet Published online 25 Oct 2012. doi: http://dx.doi.org/10.1016/S0140-6736(12)61229-X.
48. Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, et al. (2010) Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun 1: 104.
49. Hardy GH, (1908) Mendelian proportions in a mixed population. Science 28: 49-50.
50. Weinberg W, (1908) Über den nachweis der vererbung beim menschen. Jahreshefte des Vereins für vaterländische Naturkunde in Württemberg 64: 368-382.
51. Peters AL, Van Noorden CJ, (2009) Glucose-6-phosphate dehydrogenase deficiency and malaria: cytochemical detection of heterozygous G6PD deficiency in women. J Histochem Cytochem 57: 1003-1011.
52. Abdulrazzaq YM, Micallef R, Qureshi M, Dawodu A, Ahmed I, et al. (1999) Diversity in expression of glucose-6-phosphate dehydrogenase deficiency in females. Clin Genet 55: 13-19.
53. Patil AP, Gething PW, Piel FB, Hay SI, (2011) Bayesian geostatistics in health cartography: the perspective of malaria. Trends Parasitol 27: 246-253.
54. Balk DL, Deichmann U, Yetman G, Pozzi F, Hay SI, et al. (2006) Determining global population distribution: methods, applications and data. Adv Parasitol 62: 119-156.
55. United Nations Department of Economics and Social Affairs (2011) World population prospects, the 2010 Revision. New York: United Nationals Population Division.
56. Yoshida A, Beutler E, Motulsky AG, (1971) Human glucose-6-phosphate dehydrogenase variants. Bull World Health Organ 45: 243-253.
57. Gething PW, Elyazar IR, Moyes CL, Smith DL, Battle KE, et al. (2012) A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis 6: e1814 doi:10.1371/journal.pntd.0001814.
58. Guindo A, Fairhurst RM, Doumbo OK, Wellems TE, Diallo DA, (2007) X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. PLoS Med 4: e66 doi:10.1371/journal.pmed.0040066.
59. Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, et al. (1995) Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 376: 246-249.
60. Leslie T, Briceno M, Mayan I, Mohammed N, Klinkenberg E, et al. (2010) The impact of phenotypic and genotypic G6PD deficiency on risk of Plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan. PLoS Med 7: e1000283 doi:10.1371/journal.pmed.1000283.
61. Louicharoen C, Patin E, Paul R, Nuchprayoon I, Witoonpanich B, et al. (2009) Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians. Science 326: 1546-1549.
62. Hedrick PW, (2011) Population genetics of malaria resistance in humans. Heredity (Edinb) 107: 283-304.
63. Luzzatto L, (2012) G6PD deficiency and malaria selection. Heredity (Edinb) 108: 456.
64. Minucci A, Moradkhani K, Hwang MJ, Zuppi C, Giardina B, et al. (2012) Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the "old" and update of the new mutations. Blood Cells Mol Dis 48: 154-165.
65. Luzzatto L (2009) Glucose-6-phosphate dehydrogenase deficiency. Orkin SH, Nathan DG, Ginsburg D, Look AT, Fisher DE, et al., editors. Nathan and Oski's hematology of infancy and childhood. 7th ed. Philadelphia: Saunders.
66. Baird JK, (2012) Chemotherapeutics challenges in developing effective treatments for the endemic malarias. Int J Parasitol In press.
67. Bousema T, Drakeley C, (2011) Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev 24: 377-410.
68. Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, et al. (2010) The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis 4: e774 doi:10.1371/journal.pntd.0000774.
69. WHO (2011) Country antimalarial drug policies: by region. Geneva: WHO.
70. Clark TG, Fry AE, Auburn S, Campino S, Diakite M, et al. (2009) Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility. Eur J Hum Genet 17: 1080-1085.
71. Dern RJ, Beutler E, Alving AS, (1954) The hemolytic effect of primaquine. II. The natural course of the hemolytic anemia and the mechanism of its self-limited character. J Lab Clin Med 44: 171-176.
72. Shekalaghe SA, ter Braak R, Daou M, Kavishe R, van den Bijllaardt W, et al. (2010) In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals. Antimicrob Agents Chemother 54: 1762-1768.
73. Johnson MK, Clark TD, Njama-Meya D, Rosenthal PJ, Parikh S, (2009) Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility. PLoS One 4: e7246 doi:10.1371/journal.pone.0007246.
74. Baird JK, (2009) Resistance to therapies for infection by Plasmodium vivax. Clin Microbiol Rev 22: 508-534.
75. Douglas NM, Anstey NM, Angus BJ, Nosten F, Price RN, (2010) Artemisinin combination therapy for vivax malaria. Lancet Infect Dis 10: 405-416.
76. Baird JK, (2011) Resistance to chloroquine unhinges vivax malaria therapeutics. Antimicrob Agents Chemother 55: 1827-1830.
77. Baird JK, (2011) Radical cure: the case for anti-relapse therapy against all malarias. Clin Infect Dis 52: 621-623.
78. Harris I, Sharrock WW, Bain LM, Gray KA, Bobogare A, et al. (2010) A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting. Malar J 9: 254.
79. WHO (2011) Consideration of mass drug administration for the containment of artemisinin resistant malaria in the greater Mekong subregion. Geneva: WHO.
80. Kim S, Nguon C, Guillard B, Duong S, Chy S, et al. (2011) Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PLoS One 6: e28357 doi:10.1371/journal.pone.0028357.
81. Gething PW, Patil AP, Smith DL, Guerra CA, Elyazar IR, et al. (2011) A new world malaria map: Plasmodium falciparum endemicity in 2010. Malar J 10: 378.